Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 11/2016

01-11-2016 | Letter to the Editor

SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis

Authors: Emilce Edith Schneeberger, Natalia Zamora, Gustavo Citera

Published in: Clinical Rheumatology | Issue 11/2016

Login to get access

Excerpt

Dear Editor: …
Literature
1.
Solmaz D, Yildirim T, Avci O, Tomas N, Akar S. (2015) Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS). Clin Rheumatol. doi:10.​1007/​s10067-015-3147-z
2.
Sommerfleck FA, Schneeberger EE, Buschiazzo EE, Maldonado Cocco JA, Citera G (2012) A simplified version of ankylosing spondylitis disease activity score (ASDAS) in patients with ankylosing spondylitis. Clin Rheumatol 31(11):1599–603CrossRefPubMed
3.
Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, Assessment of SpondyloArthritis international Society et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68(1):18–24CrossRefPubMed
4.
Machado P, Landewé R, Lie E, Kvien TK, Braun J, Baker D, Assessment of SpondyloArthritis international Society et al (2011) Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47–53CrossRefPubMed
5.
Salaffi F, Ciapetti A, Carotti M, Gasparini S, Citera G, Gutiérrez M (2014) Construct validity and responsiveness of the simplified version of ankylosing spondylitis disease activity score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Health Qual Life Outcomes 12:129CrossRefPubMedPubMedCentral
6.
Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G et al (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42(2):244–57CrossRef
7.
Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF (2009) Comparison of three rheumatoid arthritis disease activity scores in clinical routine. Scand J Rheumatol 38(5):336–41CrossRefPubMed
8.
Gülfe A, Aletaha D, Saxne T, Geborek P (2009) Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents. BMC Musculoskelet Disord 10:41CrossRefPubMedPubMedCentral
9.
Balsa A, de Miguel E, Castillo C, Peiteado D, Martín-Mola E (2010) Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology 49(4):683–90CrossRefPubMed
10.
Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loët X et al (2012) Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint Bone Spine 79(2):149–55CrossRefPubMed
Metadata
Title
SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis
Authors
Emilce Edith Schneeberger
Natalia Zamora
Gustavo Citera
Publication date
01-11-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 11/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3342-6

Other articles of this Issue 11/2016

Clinical Rheumatology 11/2016 Go to the issue

Original Article

Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA

Original Article

Is ankle involvement underestimated in rheumatoid arthritis? Results of a multicenter ultrasound study

Brief Report

No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up

Original Article

Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity

Original Article

Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet’s disease

Original Article

Low bone mineral density and vitamin d deficiency correlated with genetics and other bone markers in female Turkish immigrants in Germany
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits